| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2012 | CN101919833B Application of aromatic compounds in preparing Caspase 3 inhibitor |
| 01/11/2012 | CN101912403B Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection |
| 01/11/2012 | CN101912356B Aztreonam/arginine medicinal composition lipid microsphere injection |
| 01/11/2012 | CN101897686B Application of sodium dodecyl benzene sulfonate in preparing external medicines of rabbit sarcopticacariasis |
| 01/11/2012 | CN101890008B Amoxicillin sodium/sulbactam sodium composition microsphere injection |
| 01/11/2012 | CN101874823B Method for increasing artemisinin content of Artemisia annua by using active enzyme induction technique |
| 01/11/2012 | CN101863897B New volution compound and preparation method and application thereof |
| 01/11/2012 | CN101862328B Valsartan amlodipine capsule medicine composition and preparation method thereof |
| 01/11/2012 | CN101862319B Docetaxel combination for injection and preparation method thereof |
| 01/11/2012 | CN101856432B Preparation method of chitosan nanoparticles encapsulated tea polyphenol |
| 01/11/2012 | CN101845052B Nitrogen-containing heterocyclic ring thienopyridine ketone derivative, preparation method and application thereof |
| 01/11/2012 | CN101843613B Vitamin EC chewable tablets with high stability and preparation method thereof |
| 01/11/2012 | CN101843612B Application of isoorientin in preparation of medicament for resisting respiratory syncytial virus |
| 01/11/2012 | CN101830854B Substituted phenylhydrazones compounds, preparation method and application thereof |
| 01/11/2012 | CN101829129B Veterinary compound gentamycin sulfate injection and preparation method thereof |
| 01/11/2012 | CN101829103B Application of flavonoid quercetin dimmer as medicament for treating viral hepatitis B |
| 01/11/2012 | CN101829100B Application of flavanonol lignanoid in preparing antiviral hepatitis B medicine |
| 01/11/2012 | CN101824002B Water soluble triazole compound and synthesis method thereof |
| 01/11/2012 | CN101822688B Compound tylosin injection for animals and preparation method thereof |
| 01/11/2012 | CN101816640B Prasugrel liposome solid preparation |
| 01/11/2012 | CN101810687B Medicament for treating hyperplasia of mammary glands and preparation method thereof |
| 01/11/2012 | CN101804035B Lansoprazole preparation for injection and preparation method thereof |
| 01/11/2012 | CN101780103B Medicine compound of mecobalamin and light magnesium oxide and preparation method thereof |
| 01/11/2012 | CN101780052B Ceftizoxime sodium liposome injection |
| 01/11/2012 | CN101774958B I-type crystal of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof |
| 01/11/2012 | CN101773508B Stable Trifusal pharmaceutical composition |
| 01/11/2012 | CN101766648B Polyethylene glycol electrolyte granular preparation and production method |
| 01/11/2012 | CN101766602B Application of substituted aryl hydrazone compound serving as anti-tumor necrosis factor inhibitor medicament |
| 01/11/2012 | CN101757280B New application of traditional Chinese medicine composition in preparing medicine for reducing intestinal permeability |
| 01/11/2012 | CN101744799B Veterinary valnemulin, novel liposome formulation of the salt thereof and preparation method thereof |
| 01/11/2012 | CN101732678B Chinese medicinal powder for stopping bleeding, diminishing inflammation and promoting regeneration of mucosa |
| 01/11/2012 | CN101732383B Total sesquiterpene lactone extract of centipeda minima, preparation method and application thereof |
| 01/11/2012 | CN101732307B Medical use of guaifenesin |
| 01/11/2012 | CN101716132B Febuxostat enteric preparation |
| 01/11/2012 | CN101703752B Medicinal composition spray or aerosol for treating whitevein and preparation method thereof |
| 01/11/2012 | CN101700375B Traditional Chinese medicine preparation for infantile exopathy cough |
| 01/11/2012 | CN101700225B Fat emulsion injection and production method thereof |
| 01/11/2012 | CN101695541B Composition for treating ischemic heart disease and preparation method thereof |
| 01/11/2012 | CN101684108B 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-5-thiazole formic acid and composition thereof |
| 01/11/2012 | CN101679297B LXR and FXR modulators |
| 01/11/2012 | CN101675922B Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 01/11/2012 | CN101671293B Alpha-glycosidase inhibitor compound in silkworm excrement total alkaloid and application thereof |
| 01/11/2012 | CN101664455B Chinese medicinal composition for treating lumbago and preparation method |
| 01/11/2012 | CN101647941B Composition for treating ischemic heart disease and preparation method thereof |
| 01/11/2012 | CN101647851B Medicament for treating burn and scald and preparation method thereof |
| 01/11/2012 | CN101637456B Suspension powder injection of cefamandole nafate and new application thereof |
| 01/11/2012 | CN101632509B Medicinal treatment shoe |
| 01/11/2012 | CN101606915B Novel pharmaceutical formulations of modafinil |
| 01/11/2012 | CN101601768B Chinese medicinal composition for treating tinea pedis and scabies and preparation method thereof |
| 01/11/2012 | CN101600698B Quinazolinone and isoquinolinone acetamide derivatives |
| 01/11/2012 | CN101596194B Application of palmatine in medicine for treating West Nile virus infection |
| 01/11/2012 | CN101574338B Pharmaceutical composition for restraining activity of aromatizing enzyme and application thereof |
| 01/11/2012 | CN101570539B Morphinone quaternary ammonium salt derivatives and preparation method thereof |
| 01/11/2012 | CN101543631B Microspherical substrate containing beeswax, pharmaceutical composition containing microspherical substrate and application thereof |
| 01/11/2012 | CN101534791B Compositions containing quaternary ammonium compounds |
| 01/11/2012 | CN101528226B Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 01/11/2012 | CN101522689B Pyridooxazepine progesteron receptor modulators |
| 01/11/2012 | CN101491650B Refined Yinqiao detoxification preparation and preparation method thereof |
| 01/11/2012 | CN101490004B Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| 01/11/2012 | CN101437524B Preparation of 2' ifluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| 01/11/2012 | CN101397327B Use of dihydro ginsenoside Rg2 |
| 01/11/2012 | CN101389609B Hydantoin based kinase inhibitors |
| 01/11/2012 | CN101376910B Use of miRNA genes in systemic lupus erythematosus disease diagnose and treatment |
| 01/11/2012 | CN101371840B Novel use of vinetine and analogue thereof in preparing medicine for preventing and/or treating leukemia |
| 01/11/2012 | CN101360718B Novel hydrogen sulfate salt |
| 01/11/2012 | CN101346353B Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/11/2012 | CN101346351B Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 01/11/2012 | CN101340909B Method of inhibiting flt3 kinase |
| 01/11/2012 | CN101332157B 半胱氨酸衍生物 Cysteine derivatives |
| 01/11/2012 | CN101317841B Annonaceous acetogenin high-efficiency part medicine-Ainuoning, preparation method and application thereof |
| 01/11/2012 | CN101312725B Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 01/11/2012 | CN101312723B Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/11/2012 | CN101305009B 氮杂取代的螺环衍生物 Aza-substituted spiro derivatives of |
| 01/11/2012 | CN101229366B Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 01/11/2012 | CN101228155B Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 01/11/2012 | CN101209976B Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor |
| 01/11/2012 | CN101208320B N-hydroxyamide derivatives and use thereof |
| 01/11/2012 | CN101198354B Preventive or remedy for glaucoma |
| 01/11/2012 | CN101146811B Hiv integrase inhibitors |
| 01/11/2012 | CN101138549B Mitiglinide calcium self-microemulsifying drug delivery system |
| 01/11/2012 | CN101067007B Production process of glucomannan meal |
| 01/11/2012 | CN101056629B Use of 2-phenyl-1,2-ethanediol-(di)carbamates for treating epileptogenesis and epilepsy |
| 01/11/2012 | CN101031283B Pharmaceutical compositions for drug delivery |
| 01/11/2012 | CN101027044B Oral dosage form safeguarded against abuse |
| 01/11/2012 | CN101022787B Oral dosage form safeguarded against abuse containing (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/11/2012 | CN101018780B Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 01/11/2012 | CN101002940B Medicine composition for treating polycystic renal disease and its uses |
| 01/10/2012 | USRE43098 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 01/10/2012 | US8093425 Compounds for treating proliferative disorders |
| 01/10/2012 | US8093417 Lipoxin analogs and methods for the treatment of periodontal disease |
| 01/10/2012 | US8093403 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 01/10/2012 | US8093402 Benzimidazole derivatives |
| 01/10/2012 | US8093401 Silent Information Regulators; aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting , increased mitochondrial activity, inflammation, cancer, and/or flushing; increased lifespan specially in mutant sir2 strains; imidazo[1,2-a]pyridine drivatives |
| 01/10/2012 | US8093400 Compounds useful in therapy |
| 01/10/2012 | US8093396 Benzthiazole inhibitors of poly(ADP-ribose)polymerase |
| 01/10/2012 | US8093395 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 01/10/2012 | US8093394 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093391 Process for the preparation of substantially pure palonosetron and its acid salts |
| 01/10/2012 | US8093390 Substituted fused [1,2]imidazo[4,5-C] ring compounds and methods |